SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001399529-21-000042
Filing Date
2021-02-26
Accepted
2021-02-25 20:47:38
Documents
94
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K drna-20201231.htm   iXBRL 10-K 2786072
2 EX-21.1 drna_20201231xex211.htm EX-21.1 4285
3 EX-23.1 drna_20201231xex231.htm EX-23.1 2461
4 EX-31.1 drna_20201231xex311.htm EX-31.1 7937
5 EX-31.2 drna_20201231xex312.htm EX-31.2 7914
6 EX-32.1 drna_20201231xex321.htm EX-32.1 6658
12 GRAPHIC drna-20201231_g1.jpg GRAPHIC 22788
13 GRAPHIC drna-20201231_g2.jpg GRAPHIC 155896
14 GRAPHIC drna-20201231_g3.jpg GRAPHIC 225048
  Complete submission text file 0001399529-21-000042.txt   11842805

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT drna-20201231.xsd EX-101.SCH 74403
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT drna-20201231_cal.xml EX-101.CAL 112833
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT drna-20201231_def.xml EX-101.DEF 358674
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT drna-20201231_lab.xml EX-101.LAB 844345
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT drna-20201231_pre.xml EX-101.PRE 593717
15 EXTRACTED XBRL INSTANCE DOCUMENT drna-20201231_htm.xml XML 1758703
Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36281 | Film No.: 21683142
SIC: 2834 Pharmaceutical Preparations